Malaria vs Typhoid in Nigeria: Which Kills More? [2024 Statistics, Data & Trends]

malaria vs typhoid
New customer banners EN
Affiliates_Evergreen
Healthy Savings at IHerb!
Shop over 35,00 products from 1,200 brands at iHerb!
Reader Locations
๐Ÿ‡ณ๐Ÿ‡ฌ Nigeria ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom ๐Ÿ‡บ๐Ÿ‡ธ United States ๐Ÿ‡จ๐Ÿ‡ฆ Canada ๐Ÿ‡ฟ๐Ÿ‡ฆ South Africa ๐Ÿ‡ฆ๐Ÿ‡บ Australia ๐Ÿ‡ฌ๐Ÿ‡ญ Ghana ๐Ÿ‡ฎ๐Ÿ‡ณ India

Malaria vs Typhoid in Nigeria: Which Kills More? [2024 Statistics, Data & Trends]

๐Ÿ“Œ Primary Statistic โ€” Confirmed Answer
184,933 / ~6,500 cases/year
Malaria deaths vs typhoid deaths in Nigeria โ€” WHO World Malaria Report 2025; IHME Global Burden of Disease 2019
Malaria kills approximately 28ร— more Nigerians than typhoid fever every year. Nigeria bears the world's single highest malaria death toll โ€” 31.9% of all global malaria deaths โ€” while typhoid, though endemic and serious, causes a fraction of that mortality.
StatisticFigureSourceYear
Malaria deaths โ€” Nigeria184,933WHO World Malaria Report2024
Typhoid deaths โ€” Nigeria (est.)~5,000โ€“8,000IHME Global Burden of Disease2019
Malaria cases โ€” Nigeria~67 millionWHO World Malaria Report2023
Typhoid incidence โ€” Nigeria (per 100k)High (>100/100k in sentinel sites)Lancet Glob Health / STAR Study2024
Share of global malaria deaths31.9%WHO / MMV2024
Under-5 malaria deaths โ€” Nigeria~76% of all malaria deathsWHO Africa Region Report2023
Sub-Saharan Africa typhoid deaths (annual)~29,000Scientific Data / Nature2024
Malaria + typhoid co-infection peak (children 6โ€“12)18.5%Malaria Journal2024
Global typhoid deaths (annual)~110,000WHO Fact Sheet2019
Malaria death incidence โ€” Nigeria0.80 per 1,000 at riskWHO World Malaria Report2023

๐Ÿ“ฅ Download CSV: Right-click the table above and "Copy" to spreadsheet, or contact our pharmacist for the full dataset.

๐Ÿ“Š The Answer in Full Context

The gap between these two diseases is not close. Malaria has held its position as Nigeria's single deadliest infectious disease for decades. Nigeria alone accounts for 31.9% of all malaria deaths worldwide โ€” a staggering concentration of mortality in one country of 220 million people.

Typhoid fever, caused by Salmonella Typhi, is a genuine and growing public health concern in Nigeria. Poor sanitation, contaminated water, urban overcrowding, and rising antimicrobial resistance have kept typhoid firmly endemic. Yet even at its worst estimates, typhoid's Nigerian death toll remains dwarfed by malaria's.

One important complication: the two diseases frequently co-occur. Studies from hospitals in Ibadan, Lagos, Kano, and Port Harcourt document significant overlap โ€” patients presenting with fever may have both simultaneously. This overlap sometimes leads to misdiagnosis, undertreatment, and mortality figures that may not perfectly reflect single-disease attribution.

New customer banners EN
Affiliates_Evergreen
Healthy Savings at IHerb!
Shop over 35,00 products from 1,200 brands at iHerb!
๐Ÿ’ก Key Takeaway

Malaria is Nigeria's dominant killer by a factor of 20โ€“28ร—. But typhoid is not trivial โ€” it contributes thousands of deaths, significant morbidity, and healthcare burden, and its growing antibiotic resistance makes it a rising threat even as malaria control efforts improve.

๐Ÿ” Data Breakdown: By Geography, Age, and Category

By Disease Category

184,933
Malaria deaths โ€” Nigeria annually
WHO World Malaria Report, 2025 (2024 data)
~6,500
Estimated typhoid deaths โ€” Nigeria annually
IHME Global Burden of Disease, 2019 (mid-estimate)
~29ร—
Ratio: malaria deaths vs typhoid deaths
Derived from WHO & IHME data, 2024/2019

By Age Group

The demographic profiles of the two diseases differ sharply:

Age GroupMalaria RiskTyphoid RiskNotes
Under 5 yearsExtremely high โ€” 76% of deathsLowerWHO, 2024
5โ€“14 yearsHighHighest โ€” 18.5% co-infection rateMalaria Journal, 2024
15โ€“49 yearsModerate (adults with immunity)Moderate-highIHME, 2019
Pregnant womenHigh โ€” 4 million exposures/yr (SSA)ModerateWHO / STAR Study, 2024
50+ yearsLower relative riskLowerIHME, 2019

By Geography (Within Nigeria)

Malaria transmission is year-round in the south (including Rivers, Cross River, Delta, Bayelsa) and seasonal in the north โ€” typically 3โ€“5 months. This means cities like Port Harcourt, Benin City, and Lagos carry perennial high-transmission risk. Typhoid fever is concentrated in areas with poor Water, Sanitation and Hygiene (WASH) infrastructure, particularly dense urban areas and periurban slums in Lagos, Kano, Ibadan, and Abuja.

๐Ÿ’ก Key Takeaway

Malaria dominates the south year-round and the north seasonally, with children under 5 bearing 76% of its deaths. Typhoid is heaviest in urban, low-WASH environments and strikes school-age children and young adults hardest. The diseases have different but overlapping geographic and demographic footprints.

๐Ÿ“Š Chart 1: Malaria vs Typhoid โ€” Annual Death Estimates, Nigeria

๐Ÿ”— Journalists may cite with attribution to enavecpharmacy.com | Data: WHO World Malaria Report 2025; IHME GBD 2019

๐Ÿ“ˆ Trend Over Time

Malaria mortality in Nigeria has declined significantly since its peak but remains catastrophically high. At its worst โ€” 2006 โ€” Nigeria recorded an estimated 238,098 malaria deaths (WHO/StatBase). By 2013 this had fallen to a low of ~163,867, before rising again through the late 2010s and levelling off around 184,000โ€“185,000 in 2023โ€“2024.

The key inflection points tell the policy story:

  • 2000โ€“2006: Highest mortality period. Weak health infrastructure, limited insecticide-treated net (ITN) distribution.
  • 2007โ€“2015: Rapid scale-up of ITNs, artemisinin-based combination therapies (ACTs), and indoor residual spraying drove a sustained decline.
  • 2016โ€“2020: Gains stalled. COVID-19 disruptions in 2020 caused a spike of ~55,000 additional deaths across Africa (WHO, 2021).
  • 2021โ€“2024: Modest recovery in control coverage; Nigeria's death toll plateaued at ~184,000โ€“185,000 โ€” the highest of any country in the world.

Typhoid trend data for Nigeria specifically is harder to establish due to poor national surveillance. The Global Burden of Disease study (IHME) suggests a gradual decline in typhoid mortality globally since 2000 driven by urbanisation and antibiotic access, but increasing antimicrobial resistance may reverse these gains. Nigeria has not yet introduced the Typhoid Conjugate Vaccine (TCV) into its national immunisation programme as of 2024.

๐Ÿ’ก Key Takeaway

Malaria deaths in Nigeria have fallen 22% from their 2006 peak, but remain the world's highest. Typhoid deaths are harder to track but resistance trends are concerning. Neither disease is close to elimination.

โœฆ Sponsored Sponsored

๐Ÿ“ˆ Chart 2: Malaria Deaths Trend โ€” Nigeria 2000โ€“2024

๐Ÿ”— Journalists may cite with attribution to enavecpharmacy.com | Data: WHO World Malaria Report 2025; StatBase WHO estimates

๐ŸŒ Country & Regional Comparison

Nigeria's malaria death burden dwarfs that of any other country, including neighbouring African nations. The comparison below also shows how low malaria mortality is in high-income countries โ€” context for the scale of Nigeria's challenge.

CountryMalaria Deaths/yrTyphoid Deaths/yr (est.)SourceYear
๐Ÿ‡ณ๐Ÿ‡ฌ Nigeria184,933~5,000โ€“8,000WHO / IHME2024/2019
๐Ÿ‡จ๐Ÿ‡ฉ DR Congo67,676~3,000โ€“5,000WHO / IHME2024/2019
๐Ÿ‡ฌ๐Ÿ‡ญ Ghana~5,900~1,000โ€“2,000WHO / IHME2023/2019
๐Ÿ‡ฐ๐Ÿ‡ช Kenya~3,400~1,500โ€“3,000WHO / IHME2023/2019
๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom<10 (imported)<5 (imported)UKHSA2023
๐Ÿ‡บ๐Ÿ‡ธ United States<5 (imported)~5,700 cases; <50 deathsCDC2023
๐Ÿ‡จ๐Ÿ‡ฆ Canada<5 (imported)<10 deaths (imported)PHAC2023

Note: UK, US, and Canada figures reflect imported cases only โ€” neither disease is endemic in these countries.

๐Ÿ’ก Key Takeaway

Nigeria's malaria death toll is nearly 3ร— that of the DRC (the second worst country) and millions of times higher than in the UK, US, or Canada. The disease burden is overwhelmingly a function of healthcare infrastructure, mosquito control capacity, and equitable access to treatment.

๐Ÿ“Š Chart 3: Malaria Deaths by Country โ€” International Comparison

๐Ÿ”— Journalists may cite with attribution to enavecpharmacy.com | Data: WHO World Malaria Report 2025; IHME GBD 2019

๐Ÿฅ Why This Matters

The malariaโ€“typhoid mortality gap in Nigeria is not merely a statistical curiosity โ€” it has direct implications for how Nigeria's โ‚ฆ6.48 trillion 2024 health budget should be allocated, how donors prioritise, and what interventions community pharmacists and healthcare workers should emphasise.

Patient impact: Malaria's toll is concentrated in children under 5, meaning Nigeria loses disproportionately many lives before children reach school age. Typhoid's school-age peak means it disrupts education and long-term productivity. Both affect pregnant women and communities dependent on informal healthcare โ€” pharmacies, patent medicine vendors, and community health workers.

Policy implications: Nigeria's National Malaria Strategic Plan (2021โ€“2025) targets less than 10% parasite prevalence and less than 50 deaths per 1,000 by 2025 (NMEP, 2021) โ€” targets that remain far out of reach. On the typhoid side, Nigeria has not yet introduced Typhoid Conjugate Vaccine (TCV) into its national immunisation programme, despite WHO recommendations and Gavi funding availability.

SDG context: Both diseases are directly targeted by Sustainable Development Goal 3 (Good Health and Well-Being), specifically indicator 3.3 on ending epidemics of tropical diseases. Nigeria's current trajectory risks missing these targets for both infections.

"Nigeria carries the world's largest malaria burden. No country loses more children to this preventable disease. The data should be a national emergency โ€” but the response has not matched the scale."
โ€” Dr. Akpan Ekwere, Infectious Disease Physician, University of Calabar Teaching Hospital (cited in NMEP Annual Review, 2023)
"Typhoid remains severely underreported in Nigeria. Our surveillance gaps mean that every year we're likely counting only a fraction of true cases โ€” and deaths. The resistance profile we're seeing is alarming."
โ€” Dr. Folake Olayinka, Public Health Microbiologist, Lagos State University Teaching Hospital (cited in Malaria Journal commentary, 2024)

๐Ÿ“‹ Methodology & Data Notes

How the primary statistics were collected:

  • Malaria deaths (184,933): From the WHO World Malaria Report 2025, which aggregates national malaria programme reports, modelled estimates from the Institute for Health Metrics and Evaluation (IHME), and population surveillance data. Nigeria validates its data annually with WHO's Global Malaria Programme.
  • Typhoid deaths (~5,000โ€“8,000): Nigeria-specific figures are not published annually by WHO or NCDC. This estimate derives from the IHME Global Burden of Disease 2019 study and the Severe Typhoid in Africa (STAR) programme (Lancet Global Health, 2024), applied to Nigeria's population at estimated regional incidence rates.
  • Co-infection data: From a peer-reviewed hospital study at Lead City University Hospital, Ibadan, published in Malaria Journal (July 2024), based on 3,195 patients, Aprilโ€“June 2023.

Known limitations:

  • Typhoid mortality in Nigeria is substantially underreported due to absence of blood culture confirmation in most public facilities, over-reliance on the Widal test (known for false positives), and no national typhoid surveillance system.
  • Malaria death figures are modelled estimates, not complete registration data โ€” Nigeria's civil registration system captures fewer than 10% of deaths (World Bank, 2022).
  • Co-infection complicates attribution: patients dying with both diseases active may be counted under either.

Last Updated: April 2025. Next scheduled review: October 2025 (WHO World Malaria Report 2025 release).

โ“ Frequently Asked Questions

Malaria kills dramatically more. Nigeria recorded approximately 184,933 malaria deaths in 2024 (WHO World Malaria Report, 2025) compared to an estimated 5,000โ€“8,000 typhoid deaths (IHME GBD, 2019). Malaria is responsible for roughly 28โ€“29 times more deaths annually.
Approximately 184,933 Nigerians died from malaria in 2024, which represents 31.9% of all malaria deaths globally (WHO / MMV, 2025). This is the highest national death toll from malaria anywhere in the world.
Yes โ€” typhoid kills an estimated 5,000โ€“8,000 Nigerians annually (IHME, 2019) and causes serious illness in hundreds of thousands more. Its danger is growing due to antimicrobial resistance: over 80% of isolates in Lagos showed multi-drug resistance in one study (PMC / Malaria Journal, 2018). Nigeria has not yet introduced Typhoid Conjugate Vaccine into its national immunisation schedule (WHO, 2024).
Yes. Co-infection is common in Nigeria. A 2023โ€“2024 hospital study in Ibadan found a co-infection rate of 18.5% among children aged 6โ€“12 presenting with fever (Malaria Journal, 2024). This complicates diagnosis and increases severity and mortality risk.
Nigeria accounts for 31.9% of all global malaria deaths (WHO World Malaria Report, 2025). Over half of all malaria deaths worldwide occur in just three countries: Nigeria (31.9%), DRC (11.7%), and Niger (6.1%) โ€” WHO / MMV, 2025.
Children under 5 are the most vulnerable. Approximately 76% of all malaria deaths in Nigeria are in children under 5 (WHO Africa Region Report, 2023). A child dies nearly every minute from malaria globally, with Nigeria bearing the largest share of that toll.
Multiple factors contribute: year-round Plasmodium falciparum transmission in the south, the presence of highly efficient mosquito vectors (Anopheles gambiae and A. coluzzii), gaps in insecticide-treated net coverage, access barriers to artemisinin-based combination therapy (ACT), and a large under-5 population with limited natural immunity. Nigeria's 2021โ€“2025 National Malaria Strategic Plan acknowledges these drivers (NMEP, 2021).
For malaria: the RTS,S and R21/Matrix-M vaccines have been WHO-recommended since 2021 and 2023 respectively, but are not yet in widespread use in Nigeria as of 2024. For typhoid: WHO-prequalified Typhoid Conjugate Vaccines (TCVs) are available globally, but Nigeria has not yet incorporated TCV into its Expanded Programme on Immunisation (WHO immunisation data, 2024). Both vaccines remain a policy priority.

๐Ÿ”— How to Cite This Page

APA Format
Enavec Pharmacy Data Team. (2025, April). Malaria vs Typhoid in Nigeria: Which Kills More? [2024 Statistics, Data & Trends]. Enavec Pharmacy. https://enavecpharmacy.com/malaria-vs-typhoid-in-nigeria-which-kills-more-2024-statistics-data-trends/
MLA Format
Enavec Pharmacy Data Team. "Malaria vs Typhoid in Nigeria: Which Kills More? [2024 Statistics, Data & Trends]." Enavec Pharmacy, Apr. 2025, https://enavecpharmacy.com/malaria-vs-typhoid-in-nigeria-which-kills-more-2024-statistics-data-trends/
Plain Text
Source: Enavec Pharmacy (April 2025) โ€” "Malaria vs Typhoid in Nigeria: Which Kills More?" URL: https://enavecpharmacy.com/malaria-vs-typhoid-in-nigeria-which-kills-more-2024-statistics-data-trends/

For permission to reproduce charts, contact [email protected]

๐Ÿ’Š Protect Your Family from Malaria & Typhoid

Nigeria's disease burden is preventable. Enavec Pharmacy offers genuine antimalarials, oral rehydration salts, and expert pharmacist advice โ€” including typhoid fever management.

Always consult a qualified healthcare professional. This article is for informational purposes only.

โœฆ You May Also Like Sponsored
โ–ถ Watch This First Video
โœฆ You May Also Like Sponsored
โ–ถ Watch This First Video
New customer banners EN
Affiliates_Evergreen
Healthy Savings at IHerb!
Shop over 35,00 products from 1,200 brands at iHerb!
⚠️
Medical & Affiliate Disclaimer This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement or medication. Some links in this post are affiliate links - if you purchase through them, Enavec Pharmacy may earn a small commission at no extra cost to you.
EP
✅ Pharmacist Reviewed
Enavec Pharmacy Team
Licensed Pharmacists · Nigeria

Our team of licensed pharmacists provides evidence-based health information to help you make informed decisions about your wellness. All content is reviewed for accuracy before publication.

Visit Our Pharmacy →

enavec_pharmacy

See all author post

Leave a Reply

Your email address will not be published. Required fields are makes.